An updated review of the economic burden of multiple sclerosis: direct and indirect costs
Economic Impact of Multiple Sclerosis Multiple sclerosis (MS) markedly affects not only the lives of those diagnosed but also imposes […]
Economic Impact of Multiple Sclerosis Multiple sclerosis (MS) markedly affects not only the lives of those diagnosed but also imposes […]
Study Overview The research aimed to investigate the clinical characteristics and management strategies for optic neuritis in a specific group
Study Overview The investigation into the use of subcutaneous efgartigimod for treating Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) highlights a pivotal
Study Overview In recent years, chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) has gained attention due to its debilitating nature and significant
Clinical Manifestations Optic neuritis typically presents with a variety of clinical symptoms that can vary in intensity and duration. One
Study Overview The investigation into the efficacy and safety of efgartigimod for patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) represents
Study Overview The research investigated the use of subcutaneous efgartigimod for patients suffering from chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), a
Clinical Presentation Optic neuritis is characterized by the inflammation of the optic nerve, leading to a range of visual symptoms
Study Overview The study investigates the use of efgartigimod, a novel treatment, in patients diagnosed with chronic inflammatory demyelinating polyradiculoneuropathy
Study Overview The investigation into the application of Efgartigimod, a novel therapeutic agent, focused specifically on its effects in patients